1024 related articles for article (PubMed ID: 27015647)
1. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
[TBL] [Abstract][Full Text] [Related]
2. Polymer coated gold-ferric oxide superparamagnetic nanoparticles for theranostic applications.
Abedin MR; Umapathi S; Mahendrakar H; Laemthong T; Coleman H; Muchangi D; Santra S; Nath M; Barua S
J Nanobiotechnology; 2018 Oct; 16(1):80. PubMed ID: 30316298
[TBL] [Abstract][Full Text] [Related]
3. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer.
Eyvazzadeh N; Shakeri-Zadeh A; Fekrazad R; Amini E; Ghaznavi H; Kamran Kamrava S
Lasers Med Sci; 2017 Sep; 32(7):1469-1477. PubMed ID: 28674789
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer.
Siminzar P; Omidi Y; Golchin A; Aghanejad A; Barar J
J Drug Target; 2020 Jan; 28(1):92-101. PubMed ID: 31062625
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-entrapped MUC-1 aptamer targeted dendrimer-gold hybrid nanostructure as a theranostic system for colon adenocarcinoma.
Alibolandi M; Hoseini F; Mohammadi M; Ramezani P; Einafshar E; Taghdisi SM; Ramezani M; Abnous K
Int J Pharm; 2018 Oct; 549(1-2):67-75. PubMed ID: 30048777
[TBL] [Abstract][Full Text] [Related]
6. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
[TBL] [Abstract][Full Text] [Related]
7. Gold Coated Superparamagnetic Iron Oxide Nanoparticles as Effective Nanoparticles to Eradicate Breast Cancer Cells via Photothermal Therapy.
Nassireslami E; Ajdarzade M
Adv Pharm Bull; 2018 Jun; 8(2):201-209. PubMed ID: 30023321
[No Abstract] [Full Text] [Related]
8. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
10. Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells.
Aghanejad A; Babamiri H; Adibkia K; Barar J; Omidi Y
Bioimpacts; 2018; 8(2):117-127. PubMed ID: 29977833
[No Abstract] [Full Text] [Related]
11. Fabrication and evaluation of aptamer-conjugated paclitaxel-loaded magnetic nanoparticles for targeted therapy on breast cancer cells.
Khodadadi E; Mahjoub S; Arabi MS; Najafzadehvarzi H; Nasirian V
Mol Biol Rep; 2021 Mar; 48(3):2105-2116. PubMed ID: 33635469
[TBL] [Abstract][Full Text] [Related]
12. Nanocluster of superparamagnetic iron oxide nanoparticles coated with poly (dopamine) for magnetic field-targeting, highly sensitive MRI and photothermal cancer therapy.
Wu M; Zhang D; Zeng Y; Wu L; Liu X; Liu J
Nanotechnology; 2015 Mar; 26(11):115102. PubMed ID: 25721867
[TBL] [Abstract][Full Text] [Related]
13. Biological evaluation of surface-modified magnetic nanoparticles as a platform for colon cancer cell theranostics.
Moskvin M; Babič M; Reis S; Cruz MM; Ferreira LP; Carvalho MD; Lima SAC; Horák D
Colloids Surf B Biointerfaces; 2018 Jan; 161():35-41. PubMed ID: 29040832
[TBL] [Abstract][Full Text] [Related]
14. Polydopamine-Coated Magnetic Composite Particles with an Enhanced Photothermal Effect.
Zheng R; Wang S; Tian Y; Jiang X; Fu D; Shen S; Yang W
ACS Appl Mater Interfaces; 2015 Jul; 7(29):15876-84. PubMed ID: 26151502
[TBL] [Abstract][Full Text] [Related]
15. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Characterization of Citrate-Stabilized Gold-Coated Superparamagnetic Iron Oxide Nanoparticles for Biomedical Applications.
Stein R; Friedrich B; Mühlberger M; Cebulla N; Schreiber E; Tietze R; Cicha I; Alexiou C; Dutz S; Boccaccini AR; Unterweger H
Molecules; 2020 Sep; 25(19):. PubMed ID: 32993144
[TBL] [Abstract][Full Text] [Related]
17. Superparamagnetic iron-oxide nanoparticles mPEG350- and mPEG2000-coated: cell uptake and biocompatibility evaluation.
Silva AH; Lima E; Mansilla MV; Zysler RD; Troiani H; Pisciotti MLM; Locatelli C; Benech JC; Oddone N; Zoldan VC; Winter E; Pasa AA; Creczynski-Pasa TB
Nanomedicine; 2016 May; 12(4):909-919. PubMed ID: 26767515
[TBL] [Abstract][Full Text] [Related]
18. Gd³⁺ Tethered Gold Nanorods for Combined Magnetic Resonance Imaging and Photo-Thermal Therapy.
Pitchaimani A; Duong T; Nguyen T; Maurmann L; Key J; Bossmann SH; Aryal S
J Biomed Nanotechnol; 2017 Apr; 13(4):417-26. PubMed ID: 29384618
[TBL] [Abstract][Full Text] [Related]
19. Highly versatile SPION encapsulated PLGA nanoparticles as photothermal ablators of cancer cells and as multimodal imaging agents.
Sivakumar B; Aswathy RG; Romero-Aburto R; Mitcham T; Mitchel KA; Nagaoka Y; Bouchard RR; Ajayan PM; Maekawa T; Sakthikumar DN
Biomater Sci; 2017 Feb; 5(3):432-443. PubMed ID: 28059418
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
